Breaking News Instant updates and real-time market news.

SPY

SPDR S&P 500 ETF Trust

$327.01 /

-3.66 (-1.11%)

, SPX

S&P 500

$0.00 /

+ (+0.00%)

17:09
09/21/20
09/21
17:09
09/21/20
17:09

Fed Chair Powell says economic activity picked up since depressed Q2 level

As part of his address before the U.S. House of Representatives' Committee on Financial Services set for tomorrow at 10:30AM ET, Fed Chair Powell will testify: "Economic activity has picked up from its depressed second-quarter level, when much of the economy was shut down to stem the spread of the virus. Many economic indicators show marked improvement. Household spending looks to have recovered about three-fourths of its earlier decline, likely owing in part to federal stimulus payments and expanded unemployment benefits. The housing sector has rebounded, and business fixed investment shows signs of improvement. In the labor market, roughly half of the 22 million payroll jobs that were lost in March and April have been regained as people return to work. Both employment and overall economic activity, however, remain well below their pre-pandemic levels, and the path ahead continues to be highly uncertain. The downturn has not fallen equally on all Americans; those least able to bear the burden have been the most affected. The rise in joblessness has been especially severe for lower-wage workers, for women, and for African-Americans and Hispanics. This reversal of economic fortune has upended many lives and created great uncertainty about the future. A full recovery is likely to come only when people are confident that it is safe to reengage in a broad range of activities. The path forward will depend on keeping the virus under control, and on policy actions taken at all levels of government." Reference Link

SPY

SPDR S&P 500 ETF Trust

$327.01 /

-3.66 (-1.11%)

SPX

S&P 500

$0.00 /

+ (+0.00%)

SPY SPDR S&P 500 ETF Trust
$327.01 /

-3.66 (-1.11%)

09/01/20
Fed's Brainard says monetary policy to pivot from stabilization to accommodation
08/17/20 Goldman Sachs
Goldman boosts end of 2020 S&P 500 target to 3,600 from 3,000
06/04/20 Keefe Bruyette
Mattis rebuke 'wake up call' for stock market, says Keefe Bruyette
03/11/20 Goldman Sachs
Goldman Sachs believes the S&P 500 bull market will soon end
SPX S&P 500
$0.00 /

+ (+0.00%)

TODAY'S FREE FLY STORIES

Downgrade
Chemours downgraded to Equal Weight ahead of PFAS news flow at Barclays » 06:17
12/04/20
12/04
06:17
12/04/20
06:17
CC

Chemours

$25.68 /

+0.19 (+0.75%)

Barclays analyst Duffy…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CC Chemours
$25.68 /

+0.19 (+0.75%)

CC Chemours
$25.68 /

+0.19 (+0.75%)

04:52 Today Barclays
Chemours downgraded to Equal Weight from Overweight at Barclays
11/30/20 Alembic Global
Chemours initiated with an Overweight at Alembic Global
11/05/20 Barclays
Chemours price target raised to $26 from $22 at Barclays
08/03/20 Barclays
Chemours price target raised to $22 from $16 at Barclays
CC Chemours
$25.68 /

+0.19 (+0.75%)

CC Chemours
$25.68 /

+0.19 (+0.75%)

CC Chemours
$25.68 /

+0.19 (+0.75%)

Initiation
Old Dominion initiated with an In Line at Evercore ISI » 06:17
12/04/20
12/04
06:17
12/04/20
06:17
ODFL

Old Dominion

$207.09 /

+2.21 (+1.08%)

Evercore ISI analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ODFL Old Dominion
$207.09 /

+2.21 (+1.08%)

ODFL Old Dominion
$207.09 /

+2.21 (+1.08%)

11/30/20 Deutsche Bank
Old Dominion price target raised to $212 from $202 at Deutsche Bank
09/23/20 Wells Fargo
Old Dominion initiated with an Equal Weight at Wells Fargo
09/07/20 Deutsche Bank
Old Dominion named 'Buy Catalyst Call' at Deutsche Bank
08/27/20 Goldman Sachs
Old Dominion price target raised to $172 from $141 at Goldman Sachs
ODFL Old Dominion
$207.09 /

+2.21 (+1.08%)

Recommendations
Domo price target raised to $60 from $53 at JMP Securities » 06:16
12/04/20
12/04
06:16
12/04/20
06:16
DOMO

Domo

$38.35 /

+1.45 (+3.93%)

JMP Securities analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
DOMO Domo
$38.35 /

+1.45 (+3.93%)

09/04/20 Needham
Domo price target raised to $61 from $47 at Needham
09/04/20 Cowen
Domo price target raised to $50 from $42 at Cowen
09/04/20 Credit Suisse
Domo price target raised to $40 from $33 at Credit Suisse
09/04/20 Morgan Stanley
Domo's vision may be 'starting to resonate,' says Morgan Stanley
DOMO Domo
$38.35 /

+1.45 (+3.93%)

DOMO Domo
$38.35 /

+1.45 (+3.93%)

DOMO Domo
$38.35 /

+1.45 (+3.93%)

Downgrade
Cabot Oil & Gas downgraded to In Line from Outperform at Evercore ISI » 06:14
12/04/20
12/04
06:14
12/04/20
06:14
COG

Cabot Oil & Gas

$15.92 /

-1.13 (-6.63%)

Evercore ISI analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
COG Cabot Oil & Gas
$15.92 /

-1.13 (-6.63%)

COG Cabot Oil & Gas
$15.92 /

-1.13 (-6.63%)

10/26/20 BofA
Cabot Oil & Gas upgraded to Neutral from Underperform at BofA
09/24/20 Tudor Pickering
Cabot Oil & Gas upgraded to Buy from Hold at Tudor Pickering
09/14/20 Northland
Cabot Oil & Gas initiated with a Market Perform at Northland
08/04/20 Credit Suisse
Cabot Oil & Gas assumed with a Neutral at Credit Suisse
COG Cabot Oil & Gas
$15.92 /

-1.13 (-6.63%)

COG Cabot Oil & Gas
$15.92 /

-1.13 (-6.63%)

Downgrade
United Airlines downgraded to Underperform from Peer Perform at Wolfe Research » 06:14
12/04/20
12/04
06:14
12/04/20
06:14
UAL

United Airlines

$49.92 /

+3.2 (+6.85%)

Wolfe Research downgraded…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
UAL United Airlines
$49.92 /

+3.2 (+6.85%)

UAL United Airlines
$49.92 /

+3.2 (+6.85%)

11/30/20
Fly Intel: Top five analyst upgrades
11/30/20 Raymond James
United Airlines upgraded to Outperform from Market Perform at Raymond James
11/30/20 Raymond James
United Airlines upgraded to Outperform from Market Perform at Raymond James
11/18/20 William Blair
Boeing 737 Max approval 'a modest positive' for ViaSat, says William Blair
UAL United Airlines
$49.92 /

+3.2 (+6.85%)

  • 22
    Apr
UAL United Airlines
$49.92 /

+3.2 (+6.85%)

UAL United Airlines
$49.92 /

+3.2 (+6.85%)

UAL United Airlines
$49.92 /

+3.2 (+6.85%)

Downgrade
Boeing downgraded to Underperform from Peer Perform at Wolfe Research » 06:14
12/04/20
12/04
06:14
12/04/20
06:14
BA

Boeing

$237.33 /

+13.53 (+6.05%)

Wolfe Research analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BA Boeing
$237.33 /

+13.53 (+6.05%)

BA Boeing
$237.33 /

+13.53 (+6.05%)

12/01/20 Truist
Triumph Group upgraded to Hold from Sell at Truist
12/01/20 Truist
Spirit AeroSystems upgraded to Hold from Sell at Truist
11/30/20 Baird
Boeing checks show lack of 737 deliveries in November, says Baird
11/19/20 Susquehanna
Boeing price target raised to $275 from $220 at Susquehanna
BA Boeing
$237.33 /

+13.53 (+6.05%)

BA Boeing
$237.33 /

+13.53 (+6.05%)

BA Boeing
$237.33 /

+13.53 (+6.05%)

BA Boeing
$237.33 /

+13.53 (+6.05%)

Recommendations
DocuSign price target raised to $276 from $261 at JMP Securities » 06:13
12/04/20
12/04
06:13
12/04/20
06:13
DOCU

DocuSign

$231.09 /

+13.52 (+6.21%)

JMP Securities analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
DOCU DocuSign
$231.09 /

+13.52 (+6.21%)

DOCU DocuSign
$231.09 /

+13.52 (+6.21%)

11/30/20 Baird
DocuSign Q3results expected to show another strong quarter, says Baird
11/23/20 Citi
DocuSign price target raised to $257 from $250 at Citi
11/18/20
Fly Intel: Top five analyst initiations
11/18/20 Needham
DocuSign initiated with a Buy at Needham
DOCU DocuSign
$231.09 /

+13.52 (+6.21%)

DOCU DocuSign
$231.09 /

+13.52 (+6.21%)

DOCU DocuSign
$231.09 /

+13.52 (+6.21%)

DOCU DocuSign
$231.09 /

+13.52 (+6.21%)

Recommendations
Northern Dynasty price target lowered to 80c from $3.25 at H.C. Wainwright » 06:13
12/04/20
12/04
06:13
12/04/20
06:13
NAK

Northern Dynasty

$0.36 /

+0.0239 (+7.03%)

H.C. Wainwright analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
NAK Northern Dynasty
$0.36 /

+0.0239 (+7.03%)

NAK Northern Dynasty
$0.36 /

+0.0239 (+7.03%)

11/09/20 TD Securities
Northern Dynasty price target lowered to C$1.15 from C$1.70 at TD Securities
07/28/20 BMO Capital
Northern Dynasty price target raised to C$3.50 from C$1.50 at BMO Capital
06/29/20 TD Securities
Northern Dynasty price target raised to C$2.25 from C$1.30 at TD Securities
05/14/20 TD Securities
Northern Dynasty price target raised to C$1.30 from C$0.75 at TD Securities
  • 11
    May
NAK Northern Dynasty
$0.36 /

+0.0239 (+7.03%)

Syndicate
Silverback Therapeutics 11.5M share IPO priced at $21.00 » 06:13
12/04/20
12/04
06:13
12/04/20
06:13
SBTX

Silverback Therapeutics

$0.00 /

+ (+0.00%)

The deal size was…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
  • 04
    Dec
Initiation
Kymera Therapeutics initiated with a Buy at H.C. Wainwright » 06:12
12/04/20
12/04
06:12
12/04/20
06:12
KYMR

Kymera Therapeutics

$50.93 /

-0.07 (-0.14%)

H.C. Wainwright analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
KYMR Kymera Therapeutics
$50.93 /

-0.07 (-0.14%)

KYMR Kymera Therapeutics
$50.93 /

-0.07 (-0.14%)

11/24/20 Morgan Stanley
Kymera Therapeutics price target raised to $45 from $27 at Morgan Stanley
11/13/20 Piper Sandler
Kymera Therapeutics initiated with an Overweight at Piper Sandler
09/15/20 Morgan Stanley
Kymera Therapeutics initiated with an Equal Weight at Morgan Stanley
09/15/20 Cowen
Cowen starts Kymera at Outperform, sees platform positioned for success
  • 21
    Aug
KYMR Kymera Therapeutics
$50.93 /

-0.07 (-0.14%)

Initiation
Liquidia Technologies initiated with a Buy at H.C. Wainwright » 06:11
12/04/20
12/04
06:11
12/04/20
06:11
LQDA

Liquidia Technologies

$2.91 /

-0.04 (-1.36%)

H.C. Wainwright analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
LQDA Liquidia Technologies
$2.91 /

-0.04 (-1.36%)

LQDA Liquidia Technologies
$2.91 /

-0.04 (-1.36%)

11/20/20
Fly Intel: Top five analyst downgrades
11/20/20 Wedbush
Liquidia Technologies downgraded to Neutral from Outperform at Wedbush
11/20/20 Wedbush
Liquidia Technologies downgraded to Neutral from Outperform at Wedbush
10/15/20 Wedbush
Liquidia Technologies price target lowered to $20 from $38 at Wedbush
LQDA Liquidia Technologies
$2.91 /

-0.04 (-1.36%)

  • 30
    Jun
  • 24
    Dec
LQDA Liquidia Technologies
$2.91 /

-0.04 (-1.36%)

LQDA Liquidia Technologies
$2.91 /

-0.04 (-1.36%)

Syndicate
Seer 9.21M share IPO priced at $19.00 » 06:11
12/04/20
12/04
06:11
12/04/20
06:11
SEER

Seer

$0.00 /

+ (+0.00%)

The deal size was…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
  • 04
    Dec
Recommendations
Tracon Pharmaceuticals price target raised to $12 from $7 at H.C. Wainwright » 06:10
12/04/20
12/04
06:10
12/04/20
06:10
TCON

Tracon Pharmaceuticals

$9.10 /

-0.21 (-2.26%)

H.C. Wainwright analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
TCON Tracon Pharmaceuticals
$9.10 /

-0.21 (-2.26%)

TCON Tracon Pharmaceuticals
$9.10 /

-0.21 (-2.26%)

09/17/20 H.C. Wainwright
Tracon Pharmaceuticals price target raised to $7 from $4 at H.C. Wainwright
04/24/20 H.C. Wainwright
Tracon Pharmaceuticals price target lowered to $4 from $6 at H.C. Wainwright
03/10/20 H.C. Wainwright
Tracon Pharmaceuticals price target lowered to $6 from $13 at H.C. Wainwright
02/28/20 H.C. Wainwright
Tracon Pharmaceuticals price target lowered to $13 from $18 at H.C. Wainwright
TCON Tracon Pharmaceuticals
$9.10 /

-0.21 (-2.26%)

TCON Tracon Pharmaceuticals
$9.10 /

-0.21 (-2.26%)

Downgrade
Ollie's Bargain Outlet downgraded to Neutral from Buy at Goldman Sachs » 06:10
12/04/20
12/04
06:10
12/04/20
06:10
OLLI

Ollie's Bargain Outlet

$89.54 /

+2.7 (+3.11%)

Goldman Sachs analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
OLLI Ollie's Bargain Outlet
$89.54 /

+2.7 (+3.11%)

OLLI Ollie's Bargain Outlet
$89.54 /

+2.7 (+3.11%)

11/18/20 Berenberg
Ollie's Bargain Outlet initiated with a Hold at Berenberg
11/02/20
Fly Intel: Top five analyst downgrades
11/02/20 Wells Fargo
Ollie's Bargain Outlet downgraded to Underweight from Overweight at Wells Fargo
08/28/20 Craig-Hallum
Ollie's Bargain Outlet price target raised to $128 from $120 at Craig-Hallum
OLLI Ollie's Bargain Outlet
$89.54 /

+2.7 (+3.11%)

OLLI Ollie's Bargain Outlet
$89.54 /

+2.7 (+3.11%)

Initiation
Jounce Therapeutics assumed with a Buy at H.C. Wainwright » 06:09
12/04/20
12/04
06:09
12/04/20
06:09
JNCE

Jounce Therapeutics

$6.90 /

+0.17 (+2.53%)

H.C. Wainwright analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
JNCE Jounce Therapeutics
$6.90 /

+0.17 (+2.53%)

JNCE Jounce Therapeutics
$6.90 /

+0.17 (+2.53%)

11/10/20 Roth Capital
Jounce Therapeutics price target lowered to $15 from $28 at Roth Capital
11/03/20 Raymond James
Jounce downgraded to Market Perform from Strong Buy at Raymond James
11/02/20 Raymond James
Jounce Therapeutics downgraded to Market Perform at Raymond James
11/02/20 Raymond James
Jounce Therapeutics downgraded to Market Perform from Strong Buy at Raymond James
JNCE Jounce Therapeutics
$6.90 /

+0.17 (+2.53%)

Recommendations
Ulta Beauty price target raised to $345 from $300 at Piper Sandler » 06:08
12/04/20
12/04
06:08
12/04/20
06:08
ULTA

Ulta Beauty

$289.51 /

+7.8 (+2.77%)

Piper Sandler analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ULTA Ulta Beauty
$289.51 /

+7.8 (+2.77%)

ULTA Ulta Beauty
$289.51 /

+7.8 (+2.77%)

11/30/20 JPMorgan
Ulta Beauty price target raised to $330 from $260 at JPMorgan
11/24/20
Fly Intel: Top five analyst downgrades
11/24/20 OTR Global
Ulta Beauty upgraded to Mixed from Negative at OTR Global
11/24/20 Jefferies
Jefferies downgrades Ulta Beauty to Hold after holiday spending survey
ULTA Ulta Beauty
$289.51 /

+7.8 (+2.77%)

ULTA Ulta Beauty
$289.51 /

+7.8 (+2.77%)

ULTA Ulta Beauty
$289.51 /

+7.8 (+2.77%)

ULTA Ulta Beauty
$289.51 /

+7.8 (+2.77%)

Periodicals
Meredith won't voluntarily recognize editorial union, NY Post reports » 06:08
12/04/20
12/04
06:08
12/04/20
06:08
MDP

Meredith

$20.54 /

+0.23 (+1.13%)

The News Guild of New…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
MDP Meredith
$20.54 /

+0.23 (+1.13%)

MDP Meredith
$20.54 /

+0.23 (+1.13%)

08/14/20
Fly Intel: Top five analyst downgrades
08/14/20 Benchmark
Meredith downgraded to Hold from Buy at Benchmark
08/14/20 Benchmark
Meredith downgraded to Hold from Buy at Benchmark
06/29/20 Citi
Meredith price target lowered to $18 from $20 at Citi
MDP Meredith
$20.54 /

+0.23 (+1.13%)

MDP Meredith
$20.54 /

+0.23 (+1.13%)

MDP Meredith
$20.54 /

+0.23 (+1.13%)

Downgrade
Dish downgraded to Neutral from Buy at Guggenheim » 06:07
12/04/20
12/04
06:07
12/04/20
06:07
DISH

Dish

$37.18 /

+0.2 (+0.54%)

Guggenheim downgraded…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
DISH Dish
$37.18 /

+0.2 (+0.54%)

DISH Dish
$37.18 /

+0.2 (+0.54%)

11/18/20 Deutsche Bank
Dish price target lowered to $65 from $69 at Deutsche Bank
11/12/20 Raymond James
Dish price target raised to $58 from $50 at Raymond James
07/20/20 Credit Suisse
F5 Networks price target raised to $170 from $151 at Credit Suisse
07/16/20 JPMorgan
Dish resumed with a Neutral from Overweight at JPMorgan
DISH Dish
$37.18 /

+0.2 (+0.54%)

DISH Dish
$37.18 /

+0.2 (+0.54%)

DISH Dish
$37.18 /

+0.2 (+0.54%)

DISH Dish
$37.18 /

+0.2 (+0.54%)

Downgrade
Stitch Fix downgraded to Sell from Neutral at MKM Partners » 06:07
12/04/20
12/04
06:07
12/04/20
06:07
SFIX

Stitch Fix

$38.05 /

-1.38 (-3.50%)

MKM Partners analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SFIX Stitch Fix
$38.05 /

-1.38 (-3.50%)

SFIX Stitch Fix
$38.05 /

-1.38 (-3.50%)

12/03/20
Fly Intel: Top five analyst downgrades
12/03/20 Wells Fargo
Stitch Fix downgraded to Underweight from Equal Weight at Wells Fargo
12/03/20 Wells Fargo
Stitch Fix downgraded to Underweight from Equal Weight at Wells Fargo
12/02/20 Needham
Stitch Fix price target raised to $46 from $34 at Needham
SFIX Stitch Fix
$38.05 /

-1.38 (-3.50%)

SFIX Stitch Fix
$38.05 /

-1.38 (-3.50%)

SFIX Stitch Fix
$38.05 /

-1.38 (-3.50%)

Downgrade
Delta Air Lines downgraded to Underperform from Peer Perform at Wolfe Research » 06:07
12/04/20
12/04
06:07
12/04/20
06:07
DAL

Delta Air Lines

$42.97 /

+1.88 (+4.58%)

Wolfe Research downgraded…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
DAL Delta Air Lines
$42.97 /

+1.88 (+4.58%)

DAL Delta Air Lines
$42.97 /

+1.88 (+4.58%)

11/30/20
Fly Intel: Top five analyst downgrades
11/30/20 Raymond James
Delta Air Lines downgraded to Market Perform from Outperform at Raymond James
11/30/20 Raymond James
Delta Air Lines downgraded to Market Perform from Outperform at Raymond James
11/17/20 Jefferies
Delta Air Lines initiated with a Hold at Jefferies
DAL Delta Air Lines
$42.97 /

+1.88 (+4.58%)

DAL Delta Air Lines
$42.97 /

+1.88 (+4.58%)

DAL Delta Air Lines
$42.97 /

+1.88 (+4.58%)

DAL Delta Air Lines
$42.97 /

+1.88 (+4.58%)

Hot Stocks
Greenbrier Marine delivers OSG 205 oil, chemical tank barge » 06:06
12/04/20
12/04
06:06
12/04/20
06:06
GBX

Greenbrier

$33.87 /

+0.075 (+0.22%)

Greenbrier Marine, a…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
GBX Greenbrier
$33.87 /

+0.075 (+0.22%)

GBX Greenbrier
$33.87 /

+0.075 (+0.22%)

08/27/20
Fly Intel: Top five analyst downgrades
08/27/20 KeyBanc
Greenbrier downgraded at KeyBanc on slow rebound in domestic railcar orders
08/27/20 KeyBanc
Greenbrier downgraded to Sector Weight from Overweight at KeyBanc
07/13/20
Fly Intel: Top five analyst upgrades
GBX Greenbrier
$33.87 /

+0.075 (+0.22%)

GBX Greenbrier
$33.87 /

+0.075 (+0.22%)

Hot Stocks
Overseas Shipholding, Greenbrier announce second new barge delivery » 06:06
12/04/20
12/04
06:06
12/04/20
06:06
OSG

Overseas Shipholding

$2.05 /

-0.02 (-0.97%)

, GBX

Greenbrier

$33.87 /

+0.075 (+0.22%)

Overseas Shipholding…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
GBX Greenbrier
$33.87 /

+0.075 (+0.22%)

OSG Overseas Shipholding
$2.05 /

-0.02 (-0.97%)

GBX Greenbrier
$33.87 /

+0.075 (+0.22%)

08/27/20
Fly Intel: Top five analyst downgrades
08/27/20 KeyBanc
Greenbrier downgraded at KeyBanc on slow rebound in domestic railcar orders
08/27/20 KeyBanc
Greenbrier downgraded to Sector Weight from Overweight at KeyBanc
07/13/20
Fly Intel: Top five analyst upgrades
GBX Greenbrier
$33.87 /

+0.075 (+0.22%)

GBX Greenbrier
$33.87 /

+0.075 (+0.22%)

Periodicals
Apollo Global reprimanded in bogus expense trial, FT reports » 06:05
12/04/20
12/04
06:05
12/04/20
06:05
APO

Apollo Global

$46.64 /

+0.62 (+1.35%)

Apollo Global was…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
APO Apollo Global
$46.64 /

+0.62 (+1.35%)

APO Apollo Global
$46.64 /

+0.62 (+1.35%)

11/06/20
Fly Intel: Top five analyst upgrades
11/06/20 Morgan Stanley
Morgan Stanley upgrades Apollo Global to Overweight following underperformance
11/06/20 Morgan Stanley
Apollo Global upgraded to Overweight from Equal Weight at Morgan Stanley
10/29/20 BMO Capital
Apollo Global upgraded to Outperform from Market Perform at BMO Capital
APO Apollo Global
$46.64 /

+0.62 (+1.35%)

APO Apollo Global
$46.64 /

+0.62 (+1.35%)

APO Apollo Global
$46.64 /

+0.62 (+1.35%)

APO Apollo Global
$46.64 /

+0.62 (+1.35%)

Upgrade
Falcon Minerals upgraded to Overweight from Neutral at Piper Sandler » 06:05
12/04/20
12/04
06:05
12/04/20
06:05
FLMN

Falcon Minerals

$2.25 /

-0.095 (-4.05%)

Piper Sandler analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
FLMN Falcon Minerals
$2.25 /

-0.095 (-4.05%)

03/30/20 Citi
Falcon Minerals price target lowered to $4 from $8 at Citi
03/19/20 Credit Suisse
Falcon Minerals assumed with a Neutral at Credit Suisse
03/13/20 Northland
Falcon Minerals downgraded to Market Perform from Outperform at Northland
03/02/20 Piper Sandler
Falcon Minerals initiated with a Neutral at Piper Sandler
FLMN Falcon Minerals
$2.25 /

-0.095 (-4.05%)

FLMN Falcon Minerals
$2.25 /

-0.095 (-4.05%)

Hot Stocks
Takeda Pharmaceutical: New Phase 3 data show TAK-620 meets primary endpoint » 06:05
12/04/20
12/04
06:05
12/04/20
06:05
TAK

Takeda Pharmaceutical

$18.41 /

+0.08 (+0.44%)

Takeda Pharmaceutical…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
TAK Takeda Pharmaceutical
$18.41 /

+0.08 (+0.44%)

TAK Takeda Pharmaceutical
$18.41 /

+0.08 (+0.44%)

06/18/20 RBC Capital
Neurocrine price target raised to $135 from $116 at RBC Capital
06/17/20 Oppenheimer
Takeda deal expands Neurocrine's pipeline into psychiatry, says Oppenheimer
04/20/20 SVB Leerink
Ascendis Pharma price target raised to $170 from $152 at SVB Leerink
03/25/20 Piper Sandler
Piper Sandler backs Overweight on 'well capitalized' Exelixis
TAK Takeda Pharmaceutical
$18.41 /

+0.08 (+0.44%)

TAK Takeda Pharmaceutical
$18.41 /

+0.08 (+0.44%)

TAK Takeda Pharmaceutical
$18.41 /

+0.08 (+0.44%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.